Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Turkey Poised To Stretch Consumer Health Market; Rigid On Ads, Access

Executive Summary

Some 80 pharmaceutical and vitamin products already are available nonprescription in parts of Turkey, but a proposal in development for almost two years would be the country's first regulation for sales of consumer health care products.

You may also be interested in...



Pharmacists Stall Turkey's Launch Of Regulated Consumer Health Market

Turkish regulators published a list of 241 products, based on 62 ingredients, selected to become available nonprescription but withdrew it after pharmacists argued that consumers in the country typically are not knowledgeable about health care issues and might buy the wrong drug product without a doctor’s advice.

Pharmacists Stall Turkey's Launch Of Regulated Consumer Health Market

Turkish regulators published a list of 241 products, based on 62 ingredients, selected to become available nonprescription but withdrew it after pharmacists argued that consumers in the country typically are not knowledgeable about health care issues and might buy the wrong drug product without a doctor’s advice.

Will Turkey Ever Regulate Its OTC Market?

Turkey’s Ministry of Health has announced work on extending the list of non-prescription medicines to reduce the financial burden on the country's Social Security Institution. However, Turkey first needs to take other steps to open up its marketplace for non-prescription drugs.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS121619

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel